期刊文献+

人腺病毒3型检测细胞系的构建与鉴定

Construction and identification of HAdV3 detection cell line
原文传递
导出
摘要 目的构建人腺病毒3型(human adenovirus type 3,HAdV3)检测细胞系。方法将HAdV3中的hexon基因克隆至绿色荧光蛋白EGFP3型基因上,连接慢病毒表达载体(PLV-Puro)上,获得PLV-EGFP-hexon。将其与包装质粒P-Pax、PMD用脂质体Lip2000共转染293T细胞,获得慢病毒颗粒感染HEp-2细胞,经嘌呤霉素压力筛选和系列的释法,获得人腺病毒3型感染的检测细胞系HEp-2/GFP。结果细胞系HEp-2/GFP感染HAdV3后24h,可观察到GFP表达的绿色荧光,而作为对照组的HEp-2/GFP细胞感染双链DNA病毒[如EB病毒(EBV)、乙型肝炎病毒(HBV)等],并未观察到绿色荧光。此检测细胞系用不同滴度的HAdV3感染,至少可以检测到10PFU/ml滴度的HAdV3。结论成功地构建了能检测HAdV3的细胞系HEp-2/GFP,且其检测的特异性和敏感性良好,可以作为检测HAdV3感染的诊断方法之一。 Objective To construct a human adenovirus type 3 detection cell line. Methods The Hexon gene of HAdV3 was cloned into green fluorescent protein gene, connected to PLV-Puro plasmid, and the PLV-EG FP-hexon plasmid was obtained and then transfected into 293T cells with the packaging plasmid P-Pax and PMD by liposome Lip2000 were transfected into . Lentivirus infected HEp-2 cells were screened after dilution of puromycin and series of pressure screening. Established cell line HEp 2/GFP was tested for detecting human adenovirus type 3 infection. Results The expression of GFP can be observed in HEp-2/GFP cells 24 hours after HAdV3 infection but not in the the control group of HEp-2/GFP cells infected with double strand DNA virus such as EBV, HBV and other viruses. The detection of cell lines with different titers of HAdV3 infec- tions can be low at 10 PFU/ml. Conclusions Cell line HEp 2/GFP was successfully constructed to detect HAdV3 with high specificity and sensitivity.
出处 《中国病毒病杂志》 CAS 2017年第4期298-302,共5页 Chinese Journal of Viral Diseases
基金 河南省基础与前沿技术研究计划项目(132300410448)
关键词 HAdV3 细胞系HEp-2/GFP PLV-Puro质粒 PLV-EGFP-hexon质粒 HAdV3 HEp-2/GFP cell line PLV-Puro PI.V-EGFP-hexon
  • 相关文献

参考文献2

二级参考文献13

  • 1许文波,崔爱利,史智扬,汪华,张勇,唐震,刘和平,李显,朱贞,唐浏英.江苏省不明原因轻型呼吸道传染病暴发的病因学研究[J].病毒学报,2005,21(5):325-331. 被引量:37
  • 2苏晓波,马鑫,洪喆瑜,吴后波,王友绍,陈凌.化学发光法中和抗体检测技术对广州地区人5型腺病毒的流行病学研究[J].南方医科大学学报,2007,27(9):1323-1326. 被引量:3
  • 3Oene therapy clinical trial worldwide. [EB/OL]. http:// www. wiley. co. uk/genrned/clinical/, updated Mareh 2008.
  • 4Bangari D S, Mittal S K. Current strategies and future directions for eluding adenoviral vector immunity [J]. Curr Gene Ther, 2006, 6 (2): 215-226.
  • 5Leopold P L, Crystal R G. Intracellular trafficking of adenovirus: many means to many ends [J]. Adv Drug Deliv Rev, 2007, 59 (8):810-821.
  • 6Tacken P J, de Vries I J, Torensma R, et al. Dendriticcell immunotherapy: from ex vivo loading to in vivo targeting [J]. Nat Rev Immunol, 2007, 7(10): 790-802.
  • 7Lyons M, Onion D, Green N K, et al. Adenovirus type 5 interactions with human blood cells may compromise systemic delivery [J]. Mol Ther. 2006, 14 (1): 118- 128.
  • 8Herold J, Tillmanns H, Xing Z, et al. Isolation and transduction of monocytes: promising vehicles for therapeutic arteriogenesis [ J]. Langenbecks Arch Surg, 2006, 391 (2): 72-82.
  • 9Mayne G C, Borowicz R A, Greeneklee K V, et al. Centrifugation facilitates transduction of green fluorescent protein in human monocytes and macrophages by adenovirus at low multiplicity of infection [J]. J Immunol Methods, 2003, 278 (1-2): 45-56.
  • 10Ho W Z, Cherukuri R, Ge S D, et al. Centrifugal enhancement of human immunodeficiency virus type 1 infection and human cytomegalovirus gene expression in human primary monocyte/macrophages in vitro[J]. J Leukoc Biol, 1993, 53 (2): 208-212.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部